(2S)-N-[(3S,22R)-14-ethyl-15-[2-(2-methoxybut-3-en-2-yl)-3-pyridinyl]-18,18-dimethyl-2,21-dioxospiro[20-oxa-1,14,25-triazahexacyclo[20.3.3.210,13.15,9.012,16.023,25]hentriaconta-5(31),6,8,10,12,15,29-heptaene-24,1'-cyclopropane]-3-yl]-3-methyl-2-[(5R)-7-[3-[(3R)-4-(oxetan-3-yl)morpholin-3-yl]prop-2-ynoyl]-1-oxo-2,7-diazaspiro[4.4]nonan-2-yl]butanamide

C65H80N8O9 — CID 167202225

IUPAC(2S)-N-[(3S,22R)-14-ethyl-15-[2-(2-methoxybut-3-en-2-yl)-3-pyridinyl]-18,18-dimethyl-2,21-dioxospiro[20-oxa-1,14,25-triazahexacyclo[20.3.3.210,13.15,9.012,16.023,25]hentriaconta-5(31),6,8,10,12,15,29-heptaene-24,1'-cyclopropane]-3-yl]-3-methyl-2-[(5R)-7-[3-[(3R)-4-(oxetan-3-yl)morpholin-3-yl]prop-2-ynoyl]-1-oxo-2,7-diazaspiro[4.4]nonan-2-yl]butanamide
SMILESC=CC(C)(OC)c1ncccc1-c1c2c3cc(ccc3n1CC)-c1cccc(c1)C[C@H](NC(=O)[C@H](C(C)C)N1CC[C@@]3(CCN(C(=O)C#C[C@@H]4COCCN4C4COC4)C3)C1=O)C(=O)N1CCC[C@@H](C(=O)OCC(C)(C)C2)C2N1C21CC1
InChIInChI=1S/C65H80N8O9/c1-9-63(7,79-8)56-47(16-12-26-66-56)55-50-35-62(5,6)40-82-60(77)48-17-13-27-72(73-57(48)65(73)22-23-65)59(76)51(33-42-14-11-15-43(32-42)44-18-20-52(49(50)34-44)69(55)10-2)67-58(75)54(41(3)4)71-29-25-64(61(71)78)24-28-68(39-64)53(74)21-19-45-36-80-31-30-70(45)46-37-81-38-46/h9,11-12,14-16,18,20,26,32,34,41,45-46,48,51,54,57H,1,10,13,17,22-25,27-31,33,35-40H2,2-8H3,(H,67,75)/t45-,48-,51+,54+,57?,63?,64-,73?/m1/s1
InChIKeyXIAGIAQYLPOZNW-XVYJKXEKSA-N
MW1117.40 g/mol
LogP6.54
Rot. Bonds10

About (2S)-N-[(3S,22R)-14-ethyl-15-[2-(2-methoxybut-3-en-2-yl)-3-pyridinyl]-18,18-dimethyl-2,21-dioxospiro[20-oxa-1,14,25-triazahexacyclo[20.3.3.210,13.15,9.012,16.023,25]hentriaconta-5(31),6,8,10,12,15,29-heptaene-24,1'-cyclopropane]-3-yl]-3-methyl-2-[(5R)-7-[3-[(3R)-4-(oxetan-3-yl)morpholin-3-yl]prop-2-ynoyl]-1-oxo-2,7-diazaspiro[4.4]nonan-2-yl]butanamide

(2S)-N-[(3S,22R)-14-ethyl-15-[2-(2-methoxybut-3-en-2-yl)-3-pyridinyl]-18,18-dimethyl-2,21-dioxospiro[20-oxa-1,14,25-triazahexacyclo[20.3.3.210,13.15,9.012,16.023,25]hentriaconta-5(31),6,8,10,12,15,29-heptaene-24,1'-cyclopropane]-3-yl]-3-methyl-2-[(5R)-7-[3-[(3R)-4-(oxetan-3-yl)morpholin-3-yl]prop-2-ynoyl]-1-oxo-2,7-diazaspiro[4.4]nonan-2-yl]butanamide (PubChem CID 167202225) has the molecular formula C65H80N8O9 and a molecular weight of 1117.40 g/mol. Its IUPAC name is (2S)-N-[(3S,22R)-14-ethyl-15-[2-(2-methoxybut-3-en-2-yl)-3-pyridinyl]-18,18-dimethyl-2,21-dioxospiro[20-oxa-1,14,25-triazahexacyclo[20.3.3.210,13.15,9.012,16.023,25]hentriaconta-5(31),6,8,10,12,15,29-heptaene-24,1'-cyclopropane]-3-yl]-3-methyl-2-[(5R)-7-[3-[(3R)-4-(oxetan-3-yl)morpholin-3-yl]prop-2-ynoyl]-1-oxo-2,7-diazaspiro[4.4]nonan-2-yl]butanamide.

Molecular Properties

Compound Name(2S)-N-[(3S,22R)-14-ethyl-15-[2-(2-methoxybut-3-en-2-yl)-3-pyridinyl]-18,18-dimethyl-2,21-dioxospiro[20-oxa-1,14,25-triazahexacyclo[20.3.3.210,13.15,9.012,16.023,25]hentriaconta-5(31),6,8,10,12,15,29-heptaene-24,1'-cyclopropane]-3-yl]-3-methyl-2-[(5R)-7-[3-[(3R)-4-(oxetan-3-yl)morpholin-3-yl]prop-2-ynoyl]-1-oxo-2,7-diazaspiro[4.4]nonan-2-yl]butanamide
PubChem CID167202225
Molecular FormulaC65H80N8O9
Molecular Weight1117.40 g/mol
Exact Mass1116.60
IUPAC Name(2S)-N-[(3S,22R)-14-ethyl-15-[2-(2-methoxybut-3-en-2-yl)-3-pyridinyl]-18,18-dimethyl-2,21-dioxospiro[20-oxa-1,14,25-triazahexacyclo[20.3.3.210,13.15,9.012,16.023,25]hentriaconta-5(31),6,8,10,12,15,29-heptaene-24,1'-cyclopropane]-3-yl]-3-methyl-2-[(5R)-7-[3-[(3R)-4-(oxetan-3-yl)morpholin-3-yl]prop-2-ynoyl]-1-oxo-2,7-diazaspiro[4.4]nonan-2-yl]butanamide
SMILESC=CC(C)(OC)c1ncccc1-c1c2c3cc(ccc3n1CC)-c1cccc(c1)C[C@H](NC(=O)[C@H](C(C)C)N1CC[C@@]3(CCN(C(=O)C#C[C@@H]4COCCN4C4COC4)C3)C1=O)C(=O)N1CCC[C@@H](C(=O)OCC(C)(C)C2)C2N1C21CC1
InChIInChI=1S/C65H80N8O9/c1-9-63(7,79-8)56-47(16-12-26-66-56)55-50-35-62(5,6)40-82-60(77)48-17-13-27-72(73-57(48)65(73)22-23-65)59(76)51(33-42-14-11-15-43(32-42)44-18-20-52(49(50)34-44)69(55)10-2)67-58(75)54(41(3)4)71-29-25-64(61(71)78)24-28-68(39-64)53(74)21-19-45-36-80-31-30-70(45)46-37-81-38-46/h9,11-12,14-16,18,20,26,32,34,41,45-46,48,51,54,57H,1,10,13,17,22-25,27-31,33,35-40H2,2-8H3,(H,67,75)/t45-,48-,51+,54+,57?,63?,64-,73?/m1/s1
InChIKeyXIAGIAQYLPOZNW-XVYJKXEKSA-N
XLogP6.54
TPSA168.09 Ų
H-Bond Donors1
H-Bond Acceptors13
Rotatable Bonds10
Heavy Atoms82
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001117.40
LogP ≤ 56.54
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'Three-membered_heterocycle', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze (2S)-N-[(3S,22R)-14-ethyl-15-[2-(2-methoxybut-3-en-2-yl)-3-pyridinyl]-18,18-dimethyl-2,21-dioxospiro[20-oxa-1,14,25-triazahexacyclo[20.3.3.210,13.15,9.012,16.023,25]hentriaconta-5(31),6,8,10,12,15,29-heptaene-24,1'-cyclopropane]-3-yl]-3-methyl-2-[(5R)-7-[3-[(3R)-4-(oxetan-3-yl)morpholin-3-yl]prop-2-ynoyl]-1-oxo-2,7-diazaspiro[4.4]nonan-2-yl]butanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S)-N-[(3S,22R)-14-ethyl-15-[2-(2-methoxybut-3-en-2-yl)-3-pyridinyl]-18,18-dimethyl-2,21-dioxospiro[20-oxa-1,14,25-triazahexacyclo[20.3.3.210,13.15,9.012,16.023,25]hentriaconta-5(31),6,8,10,12,15,29-heptaene-24,1'-cyclopropane]-3-yl]-3-methyl-2-[(5R)-7-[3-[(3R)-4-(oxetan-3-yl)morpholin-3-yl]prop-2-ynoyl]-1-oxo-2,7-diazaspiro[4.4]nonan-2-yl]butanamide?
The IUPAC name of (2S)-N-[(3S,22R)-14-ethyl-15-[2-(2-methoxybut-3-en-2-yl)-3-pyridinyl]-18,18-dimethyl-2,21-dioxospiro[20-oxa-1,14,25-triazahexacyclo[20.3.3.210,13.15,9.012,16.023,25]hentriaconta-5(31),6,8,10,12,15,29-heptaene-24,1'-cyclopropane]-3-yl]-3-methyl-2-[(5R)-7-[3-[(3R)-4-(oxetan-3-yl)morpholin-3-yl]prop-2-ynoyl]-1-oxo-2,7-diazaspiro[4.4]nonan-2-yl]butanamide (CID 167202225) is (2S)-N-[(3S,22R)-14-ethyl-15-[2-(2-methoxybut-3-en-2-yl)-3-pyridinyl]-18,18-dimethyl-2,21-dioxospiro[20-oxa-1,14,25-triazahexacyclo[20.3.3.210,13.15,9.012,16.023,25]hentriaconta-5(31),6,8,10,12,15,29-heptaene-24,1'-cyclopropane]-3-yl]-3-methyl-2-[(5R)-7-[3-[(3R)-4-(oxetan-3-yl)morpholin-3-yl]prop-2-ynoyl]-1-oxo-2,7-diazaspiro[4.4]nonan-2-yl]butanamide.
What is the SMILES notation for (2S)-N-[(3S,22R)-14-ethyl-15-[2-(2-methoxybut-3-en-2-yl)-3-pyridinyl]-18,18-dimethyl-2,21-dioxospiro[20-oxa-1,14,25-triazahexacyclo[20.3.3.210,13.15,9.012,16.023,25]hentriaconta-5(31),6,8,10,12,15,29-heptaene-24,1'-cyclopropane]-3-yl]-3-methyl-2-[(5R)-7-[3-[(3R)-4-(oxetan-3-yl)morpholin-3-yl]prop-2-ynoyl]-1-oxo-2,7-diazaspiro[4.4]nonan-2-yl]butanamide?
The canonical SMILES for (2S)-N-[(3S,22R)-14-ethyl-15-[2-(2-methoxybut-3-en-2-yl)-3-pyridinyl]-18,18-dimethyl-2,21-dioxospiro[20-oxa-1,14,25-triazahexacyclo[20.3.3.210,13.15,9.012,16.023,25]hentriaconta-5(31),6,8,10,12,15,29-heptaene-24,1'-cyclopropane]-3-yl]-3-methyl-2-[(5R)-7-[3-[(3R)-4-(oxetan-3-yl)morpholin-3-yl]prop-2-ynoyl]-1-oxo-2,7-diazaspiro[4.4]nonan-2-yl]butanamide is C=CC(C)(OC)c1ncccc1-c1c2c3cc(ccc3n1CC)-c1cccc(c1)C[C@H](NC(=O)[C@H](C(C)C)N1CC[C@@]3(CCN(C(=O)C#C[C@@H]4COCCN4C4COC4)C3)C1=O)C(=O)N1CCC[C@@H](C(=O)OCC(C)(C)C2)C2N1C21CC1.
What is the InChIKey of (2S)-N-[(3S,22R)-14-ethyl-15-[2-(2-methoxybut-3-en-2-yl)-3-pyridinyl]-18,18-dimethyl-2,21-dioxospiro[20-oxa-1,14,25-triazahexacyclo[20.3.3.210,13.15,9.012,16.023,25]hentriaconta-5(31),6,8,10,12,15,29-heptaene-24,1'-cyclopropane]-3-yl]-3-methyl-2-[(5R)-7-[3-[(3R)-4-(oxetan-3-yl)morpholin-3-yl]prop-2-ynoyl]-1-oxo-2,7-diazaspiro[4.4]nonan-2-yl]butanamide?
The InChIKey is XIAGIAQYLPOZNW-XVYJKXEKSA-N. The full InChI is InChI=1S/C65H80N8O9/c1-9-63(7,79-8)56-47(16-12-26-66-56)55-50-35-62(5,6)40-82-60(77)48-17-13-27-72(73-57(48)65(73)22-23-65)59(76)51(33-42-14-11-15-43(32-42)44-18-20-52(49(50)34-44)69(55)10-2)67-58(75)54(41(3)4)71-29-25-64(61(71)78)24-28-68(39-64)53(74)21-19-45-36-80-31-30-70(45)46-37-81-38-46/h9,11-12,14-16,18,20,26,32,34,41,45-46,48,51,54,57H,1,10,13,17,22-25,27-31,33,35-40H2,2-8H3,(H,67,75)/t45-,48-,51+,54+,57?,63?,64-,73?/m1/s1.
What are the key properties of (2S)-N-[(3S,22R)-14-ethyl-15-[2-(2-methoxybut-3-en-2-yl)-3-pyridinyl]-18,18-dimethyl-2,21-dioxospiro[20-oxa-1,14,25-triazahexacyclo[20.3.3.210,13.15,9.012,16.023,25]hentriaconta-5(31),6,8,10,12,15,29-heptaene-24,1'-cyclopropane]-3-yl]-3-methyl-2-[(5R)-7-[3-[(3R)-4-(oxetan-3-yl)morpholin-3-yl]prop-2-ynoyl]-1-oxo-2,7-diazaspiro[4.4]nonan-2-yl]butanamide?
(2S)-N-[(3S,22R)-14-ethyl-15-[2-(2-methoxybut-3-en-2-yl)-3-pyridinyl]-18,18-dimethyl-2,21-dioxospiro[20-oxa-1,14,25-triazahexacyclo[20.3.3.210,13.15,9.012,16.023,25]hentriaconta-5(31),6,8,10,12,15,29-heptaene-24,1'-cyclopropane]-3-yl]-3-methyl-2-[(5R)-7-[3-[(3R)-4-(oxetan-3-yl)morpholin-3-yl]prop-2-ynoyl]-1-oxo-2,7-diazaspiro[4.4]nonan-2-yl]butanamide has a molecular weight of 1117.40 g/mol, XLogP of 6.54, 10 rotatable bonds, 1 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-N-[(3S,22R)-14-ethyl-15-[2-(2-methoxybut-3-en-2-yl)-3-pyridinyl]-18,18-dimethyl-2,21-dioxospiro[20-oxa-1,14,25-triazahexacyclo[20.3.3.210,13.15,9.012,16.023,25]hentriaconta-5(31),6,8,10,12,15,29-heptaene-24,1'-cyclopropane]-3-yl]-3-methyl-2-[(5R)-7-[3-[(3R)-4-(oxetan-3-yl)morpholin-3-yl]prop-2-ynoyl]-1-oxo-2,7-diazaspiro[4.4]nonan-2-yl]butanamide is sourced from PubChem (CID 167202225), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).